Benign prostatic hyperplasia (BPH) is an extremely common disease of older men, occurring in more than 70 percent of men over the age of 60. BPH results in substantial morbidity in this patient ...
HSHS St. Elizabeth’s Hospital is proud to announce the 100th Aquablation therapy procedure, marking a significant milestone ...
There is a significant positive association between dietary calcium intake and benign prostatic hyperplasia (BPH), according to a study published online May 30 in Translational Andrology and Urology.
Extracts of the berries of saw palmetto, a small palm tree native to the southeastern U.S., are used widely to treat benign prostatic hyperplasia (BPH). In this randomized trial conducted in ...
The purpose of this manuscript is to provideclinicians, health plan decision makers, and policymakers with highlights of key findings pertainingto our current understanding of the condition ofenlarged ...
Dr. R K Shimpi explains Benign Prostatic Hyperplasia (BPH) and Overactive Bladder (OAB), their symptoms, causes, and modern ...
Gut Microbiota and Benign Prostatic Hyperplasia research highlights new inflammatory pathways and microbiome targets. Learn ...
Entadfi is a fixed-dose combination of finasteride, a 5α-reductase inhibitor, and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor. The Food and Drug Administration (FDA) has approved Entadfi ...
Top surgeon Henry Woo has spent plenty of time treating patients struggling with enlarged prostates — so when he started ...
Chicago, Feb. 09, 2026 (GLOBE NEWSWIRE) -- The global benign prostatic hyperplasia surgical treatment market was valued at 10.5 billion in 2024 and is expected to reach US$ 16.5 billion by 2033, ...
Drug Used for Enlarged Prostate Tied to High Glaucoma Risk The use of alpha-blockers for benign prostatic hyperplasia is tied to an increased risk of developing acute angle-closure glaucoma, a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results